Minerva Neurosciences

-$0.06 (-3.39%) Today
+$0.04 (+2.34%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NERV and other ETFs, options, and stocks.

About NERV

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease.

CEO
Rémy Henri Luthringer
Employees
11
Headquarters
Waltham, Massachusetts
Founded
2007

NERV Key Statistics

Market Cap
120.70M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
478.62K
High Today
$1.79
Low Today
$1.67
Open Price
$1.77
Volume
416.23K
52 Week High
$4.12
52 Week Low
$1.67

NERV Earnings

-$0.77
-$0.27
$0.23
$0.73
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
-$0.17 per share
Actual
-$0.25 per share
Replay Earnings Call
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure